Grants and Contributions:
Title:
BMWi AI 2020 - AIR_PTE - AI based Risk Prediction and Treatment Effect Estimation
Agreement Number:
955904
Agreement Value:
$186,300.00
Agreement Date:
Sep 21, 2020 - Dec 31, 2022
Description:
BMWi AI 2020 - Project AIR_PTE - AI based Risk Prediction and Treatment Effect Estimation based on health claims data with German partner InGef.
Macadamian is developing new digital health services that will leverage a predictive health analytics framework to support better patient outcomes leveraging historical healthcare data.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Gatineau, Quebec, CA J8X 2K5
Reference Number:
172-2020-2021-Q2-955904
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
872989587
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 101 days.
Amendment Date
Jan 11, 2022
Recipient's Legal Name:
Macadamian Technologies inc.
Federal Riding Name:
Hull--Aylmer
Federal Riding Number:
24030
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54151
Amendments: